Fig. 4.

Improvement in dogs along the treatment. The use of cannabinoids alone or combined with other medications improved clinical parameters. A scale was created to classify the improvement in middle, moderate, significant, or without changes. Bars represent the number of patients for each category. More prevalent diseases/conditions and the chemotype (Ch) used are shown. A Pain and Ch1. B Pain and Ch2. C Seizure and CH3. D Behavior disorders and Ch3. Patients were evaluated at 15, 30, and 60 days of treatment at the moment of the survey